Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
OpenAI AI Agent Swarm Behind Hugging Face Hack 
Itochu Offers $1.56 Billion to Privatize Dentsu Soken 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Toyota Global Sales Fall as China Demand Slumps 
Add as a preferred source on Google
MINNEAPOLIS, April 09, 2018 -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that first quarter 2018 financial results will be released after the market closes on Monday, May 7.
Management will host a conference call at 5:00 p.m. Eastern Time on May 7 to discuss the results of the quarter and the year with a question and answer session. Those who would like to participate may dial 833-286-5804 (647-689-4449 for international callers) and provide access code 8265599. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.
For those unable to participate, a replay of the call will be available for two weeks at 800-585-8367 (416-621-4642 for international callers); access code 8265599. The webcast will be archived at investors.tactilemedical.com.
About Tactile Medical
Tactile Medical is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and chronic venous insufficiency. Tactile Medical’s Mission is to help people suffering from chronic diseases live better and care for themselves at home. The Company’s unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.
Investor Inquiries: Mike Piccinino, CFA Managing Director Westwicke Partners 443-213-0500 [email protected]
